Presence of ARAs no contraindication to reinfusion of rituximab in pemphigus patients: JAMA Medha Baranwal19 Dec 2022 8:00 PM ISTFrance: Antirituximab antibodies (ARAs) are frequently detected in pemphigus patients treated with rituximab (RTX) and do not influence patients'...
Rituximab can halt risk of deterioration in myasthenia gravis, finds JAMA study Dr. Kamal Kant Kohli25 Sept 2022 8:30 PM ISTIn myasthenia gravis, the immune system attacks the receptors between nerves and muscles, causing abnormal muscle weakness and fatigue. It often...
Rituximab efficacious in chronic bullous disease of childhood: IDOJ Dr Manoj Kumar Nayak18 Sept 2022 7:30 PM ISTRituximab efficacious in chronic bullous disease of childhood: IDOJ Linear IgA disease (LAD) also known as chronic bullous disease of childhood...
Dr Reddy's Labs unveils cancer drug Lenalidomide in US Ruchika Sharma8 Sept 2022 2:47 PM ISTDr. Reddy's Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg,...
Steroid plus tacrolimus highly effective for Idiopathic Membranous Nephropathy regardless of proteinuria levels Medha Baranwal15 July 2022 8:00 PM ISTChina: In patients of Idiopathic Membranous Nephropathy with all degrees of proteinuria, a combo of steroids and tacrolimus showed significant...
Phase 3 SHINE results show postive results for IMBRUVICA (ibrutinib) in Mantle Cell Lymphoma Ruchika Sharma5 Jun 2022 3:00 PM ISTMCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.
Laryngeal involvement in mucous membrane pemphigoid predicts poor response to rituximab: IJDVL Dr Manoj Kumar Nayak24 Sept 2021 9:00 AM ISTLaryngeal mucous membrane pemphigoid a poor prognostic factor for rituximab treatment: IJDVL Mucous membrane pemphigoid (MMP) is an autoimmune...
Rituximab superior to Mycophenolate mofetil for complete remission of Pemphigus Vulgaris: Study Dr. Shravani Dali8 July 2021 9:15 AM ISTRituximab showed better outcomes than mycophenolate mofetil in producing continued complete remission at 52 weeks in patients suffering from...
Rituximab treatment may increase ICU admissions, mortality in COVID-19 patients: Study Medha Baranwal24 April 2021 4:31 AM ISTFrance: The administration of rituximab in patients with inflammatory rheumatic and musculoskeletal diseases is associated with more severe COVID-19...
Management of Myasthenia Gravis: International Consensus Guidance Medha Baranwal12 Feb 2021 7:37 PM ISTIsrael: The Myasthenia Gravis Foundation of America has released an updated guideline for the management of myasthenia gravis (MG).The aim of the...
Sandoz Canada launches two new biosimilars Ziextenzo, Riximyo Ruchika Sharma23 Aug 2020 10:00 AM ISTBoucherville: Sandoz Canada Inc. has announced that it has reached a negotiated agreement with the Pan-Canadian...
Cadila pharma unveils biosimilar Rituximab under brand name Ritucad Ruchika Sharma30 July 2020 1:01 PM ISTRitucad is used in the treatment of Non-Hodgkin's lymphoma( a type of blood-related cancer)
